COMMUNIQUÉS West-GlobeNewswire

Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions

12/04/2018 - 22:30

BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

ICU Medical, Inc. Announces Time of First Quarter 2018 Earnings Conference Call

12/04/2018 - 22:05

SAN CLEMENTE, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

Conformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018

12/04/2018 - 22:05

BILLERICA, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ) announced today that it will host a conference call on Wednesday, May 2, 2018, at 4:30 p.m. Eastern Time to discuss its financial [...]

Galapagos announces ISABELA Phase 3 program in IPF

12/04/2018 - 22:02

Mechelen, Belgium; 12 April 2018, 22.01 CET - Galapagos announces the design of a worldwide Phase 3 program, based on feedback from the FDA and EMA, to evaluate GLPG1690 in patients with idiopathic pulmonary fibrosis. [...]

PRA Health Sciences to Report First Quarter 2018 Earnings

12/04/2018 - 22:01

RALEIGH, N.C., April 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) will release its first quarter 2018 results after the market closes on Wednesday, April 25, 2018. The Company will also host a [...]

Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(C)(4)

12/04/2018 - 22:01

LIVONIA, Mich., April 12, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Munising Memorial Hospital Selects Cerner CommunityWorks℠

12/04/2018 - 22:01

MUNISING, Mich., April 12, 2018 (GLOBE NEWSWIRE) -- Munising Memorial Hospital (MMH) has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) across [...]

Cytokinetics to Announce First Quarter Results on April 26, 2018

12/04/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that it is scheduled to report first quarter results on April 26, 2018 at 4:00 PM Eastern Time. [...]

Athersys to Host First Quarter Financial Results Call

12/04/2018 - 22:00

CLEVELAND, April 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX ) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a [...]

PCI Biotech: Exercise of employee share options and resolution to increase the share capital

12/04/2018 - 20:54

Oslo (Norway), 12 th April 2018 - Exercise of employee share options and resolution to increase the share capital in PCI Biotech Holding ASA (the "Company"). 1. Options exercised One participant in the Company's share [...]

CORRECTION -- U.S. Undersecretary of Commerce and NIST Director Walter G. Copan Presents National Quality Award to Adventist Health

12/04/2018 - 19:09

Leading Non-Profit, Faith-Based Health System Celebrates Highest American Honor in Quality for Its Hawaiian Medical Center; Award Personally Presented in Baltimore, MD BALTIMORE, April 12, 2018 (GLOBE NEWSWIRE) -- [...]

Cynata to Present at the Preeminent Cell & Gene Therapy Investor Day in New York

12/04/2018 - 19:04

MELBOURNE, Australia, April 12, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), is pleased to announce that it has been invited to present at the [...]

Resolution passed at the Annual General Meeting

12/04/2018 - 19:02

Orphazyme A/S Company announcement No. 05/2018 Copenhagen, April 12, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today held its Annual [...]

ContraVir Pharmaceuticals Announces New Data Presented at the 2018 International Liver Congress™

12/04/2018 - 18:46

EDISON, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

12/04/2018 - 18:16

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...

12/04/2018 - 18:16

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Terveystalo Plc: Resolutions of the Organizing Meeting of Board of Directors

12/04/2018 - 18:06

Terveystalo Plc, Stock Exchange Release 12 April 2018 at 19:05 EET At its organizing meeting held after the Annual General Meeting held today, the Board of Directors of Terveystalo Plc made the following resolutions: [...]

OSE Immunotherapeutics Announces Evolution in Company’s Board of Directors and Management

12/04/2018 - 18:00

Dominique Costantini, MD, Appointed as Chairman of Company’s Board of Directors, Alexis Peyroles Appointed as Chief Executive Officer Natural, Seamless Evolution Follows Three Structuring License Agreements to Drive [...]

Arbutus Presents Complementary Results From Preclinical Combination Studies of HBV Therapeutic Candidates at EASL 2018

12/04/2018 - 18:00

Capsid inhibitor with HBV RNA Destabilizer Demonstrate Complementary Efficacy Results Subcutaneous RNAi Agent Demonstrates Durable HBsAg Reduction Following a Single Dose VANCOUVER, British Columbia and WARMINSTER, Pa [...]